Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Novavax, Inc. (the Company) on Form 10-Q for the
period ended September 30, 2005 as filed with the Securities and Exchange Commission on the date
hereof (the Report), I, Dennis W. Genge, Vice-President and Chief Financial Officer of the
Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley
Act of 2002, that:
| |
1) |
|
The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and |
| |
| |
2) |
|
The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company. |
| |
|
|
|
|
|
|
| |
|
By: /s/ Dennis W. Genge |
|
|
| |
|
|
|
|
|
|
Name:
|
|
Dennis W. Genge |
|
|
|
|
Title:
|
|
Vice President and |
|
|
|
|
|
|
Chief Financial Officer |
|
|
|
|
|
|
|
|
|
| |
|
November 8, 2005 |
|
|
35